Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.
The forward PE ratio is 16.54 as of Monday, July 27, 2026.
Forward PE Ratio (16.54) = Close Price ($169.64) / Consensus Forward EPS ($10.23)
FORWARD PE RATIO
16.54
SECTOR MEDIAN · HEALTHCARE
18.46
median of 68 covered companies
CURRENT VS SECTOR MEDIAN
-10.40%
vs the sector median at left
AstraZeneca PLC
Market Cap
$131.45B
Forward PE Ratio
16.54
| NAME | MARKET CAP | FORWARD PE RATIO |
|---|---|---|
| AstraZeneca PLC (AZN) | $131.45B | 16.54 |
| Stryker Corporation (SYK)vs › | $129.13B | 22.04 |
| Bristol-Myers Squibb Company (BMY)vs › | $127.75B | 9.79 |
| CVS Health Corp. (CVS)vs › | $136.61B | 14.46 |
| Intuitive Surgical, Inc. (ISRG)vs › | $126.06B | 31.34 |
| Danaher Corporation (DHR)vs › | $138.14B | 22.57 |
| Pfizer Inc. (PFE)vs › | $140.61B | 8.34 |
| Vertex Pharmaceuticals Incorporated (VRTX)vs › | $121.57B | 24.83 |
| Medtronic plc (MDT)vs › | $107.81B | 15.08 |
| GSK plc (GSK)vs › | $104.87B | 14.34 |
Trailing P/E
12.8
reported TTM EPS
Forward P/E
16.5
consensus next-FY EPS
The gap between the two multiples is the consensus growth expectation: analysts' forward EPS of $10.23 implies -23.0% EPS decline vs the reported trailing $13.28.
At today's $169.64 close, each upcoming fiscal year's consensus EPS implies a different multiple — how quickly the price is "paid down" by expected earnings if the estimates hold.
| Fiscal year end | Consensus EPS | Estimate range | Analysts | Implied P/E |
|---|---|---|---|---|
| 2026-12-31 | $10.23 | $10.06 – $10.32 | 7 | 16.6x |
| 2027-12-31 | $11.54 | $11.22 – $11.78 | 7 | 14.7x |
| 2028-12-31 | $12.83 | $9.51 – $13.77 | 10 | 13.2x |
Source: FMP analyst consensus estimates, refreshed with the daily precompute. "n/m" = the consensus EPS is not positive, so a multiple is undefined. There is no forward P/E history chart here because charting one would require the estimates as they stood in the past, which we do not store — see the trailing P/E history for how the realized multiple has moved.
PE Ratio = Share Price / Diluted EPS (TTM)
The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
